17th Invitation to Manufacturers of Antimalarial Medicines to submit an Expression of Interest (EOI) for product evaluation to the WHO Prequalification Team: Medicines

The revised 17th MA EOI removes scoring for a number of products. In addition, the EOI adds primaquine base 2.5 mg tablet, as well as primaquine base 5 mg tablets (scored). It also adds scoring for primaquine 7.5 and 15 mg tablets.